These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18534922)

  • 1. Enhanced adaptation of vesicular stomatitis virus in cells infected with vaccinia virus.
    Carrillo FY; Sanjuán R; Moya A; Cuevas JM
    Infect Genet Evol; 2008 Sep; 8(5):614-20. PubMed ID: 18534922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translation of mRNAs from vesicular stomatitis virus and vaccinia virus is differentially blocked in cells with depletion of eIF4GI and/or eIF4GII.
    Welnowska E; Castelló A; Moral P; Carrasco L
    J Mol Biol; 2009 Dec; 394(3):506-21. PubMed ID: 19769989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolutionary genomics of host adaptation in vesicular stomatitis virus.
    Remold SK; Rambaut A; Turner PE
    Mol Biol Evol; 2008 Jun; 25(6):1138-47. PubMed ID: 18353798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid rafts play an important role in the vesicular stomatitis virus life cycle.
    Wang W; Fu YJ; Zu YG; Wu N; Reichling J; Efferth T
    Arch Virol; 2009; 154(4):595-600. PubMed ID: 19288237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of co- and superinfection on the adaptive dynamics of vesicular stomatitis virus.
    Carrillo FY; Sanjuán R; Moya A; Cuevas JM
    Infect Genet Evol; 2007 Jan; 7(1):69-73. PubMed ID: 16807134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arrested spread of vesicular stomatitis virus infections in vitro depends on interferon-mediated antiviral activity.
    Lam V; Duca KA; Yin J
    Biotechnol Bioeng; 2005 Jun; 90(7):793-804. PubMed ID: 15834946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccinia virus-free recovery of vesicular stomatitis virus.
    Harty RN; Brown ME; Hayes FP; Wright NT; Schnell MJ
    J Mol Microbiol Biotechnol; 2001 Oct; 3(4):513-7. PubMed ID: 11545270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of evolutionary stasis during alternating replication of an arbovirus in insect and mammalian cells.
    Novella IS; Hershey CL; Escarmis C; Domingo E; Holland JJ
    J Mol Biol; 1999 Apr; 287(3):459-65. PubMed ID: 10092452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1).
    Kalhoro NH; Veits J; Rautenschlein S; Zimmer G
    Vaccine; 2009 Feb; 27(8):1174-83. PubMed ID: 19135116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of intracellular and extracellular particles of the vaccinia virus].
    Vanderplasschen A
    Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):381-7. PubMed ID: 10992888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of fitness loss and fitness recovery in vesicular stomatitis virus.
    Novella IS; Ebendick-Corpus BE
    J Mol Biol; 2004 Oct; 342(5):1423-30. PubMed ID: 15364571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular distribution of swine vesicular disease virus proteins and alterations induced in infected cells: a comparative study with foot-and-mouth disease virus and vesicular stomatitis virus.
    Martín-Acebes MA; González-Magaldi M; Rosas MF; Borrego B; Brocchi E; Armas-Portela R; Sobrino F
    Virology; 2008 May; 374(2):432-43. PubMed ID: 18279902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antiviral activity of dehydroepiandrosterone and its synthetic derivatives against vesicular stomatitis virus.
    Romanutti C; Bruttomesso AC; Castilla V; Bisceglia JA; Galagovsky LR; Wachsman MB
    Vet J; 2009 Nov; 182(2):327-35. PubMed ID: 18682333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of vesicular stomatitis (visna virus) pseudotypes to demonstrate visna virus receptors in cells from different species.
    Gilden DH; Devlin M; Wroblewska Z
    Arch Virol; 1981; 67(2):181-5. PubMed ID: 6260064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p14 FAST protein of reptilian reovirus increases vesicular stomatitis virus neuropathogenesis.
    Brown CW; Stephenson KB; Hanson S; Kucharczyk M; Duncan R; Bell JC; Lichty BD
    J Virol; 2009 Jan; 83(2):552-61. PubMed ID: 18971262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccinia virus and Cowpox virus are not susceptible to the interferon-induced antiviral protein MxA.
    Lorenzo MM; Sanchez-Puig JM; Blasco R
    PLoS One; 2017; 12(7):e0181459. PubMed ID: 28727764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-15 mediates potent antiviral responses via an interferon-dependent mechanism.
    Foong YY; Jans DA; Rolph MS; Gahan ME; Mahalingam S
    Virology; 2009 Oct; 393(2):228-37. PubMed ID: 19729181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of the antiviral effect of interferon differs in two strains of a rabbit kidney cell line.
    Whitaker-Dowling P; Kaifer C; Youngner JS
    J Interferon Res; 1987 Feb; 7(1):61-8. PubMed ID: 2438358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth and molecular evolution of vesicular stomatitis serotype New Jersey in cells derived from its natural insect-host: evidence for natural adaptation.
    Llewellyn ZN; Salman MD; Pauszek S; Rodriguez LL
    Virus Res; 2002 Oct; 89(1):65-73. PubMed ID: 12367751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus infection speeds: theory versus experiment.
    Amor DR; Fort J
    Phys Rev E Stat Nonlin Soft Matter Phys; 2010 Dec; 82(6 Pt 1):061905. PubMed ID: 21230688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.